Intervention:   doxorubicin          

    Access protocols via the Procedure column.
Data set MPD ID Procedure / Protocol Drug or Challenge Phenotype Measure Panel No. of Strains Sex Age Sample Size (Avg) Year
    Wiltshire4 52421 immune cell quantification doxorubicin B cells, percent viability   [%]     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 35 m 10wks N=4 2015
    Wiltshire4 52427 immune cell quantification doxorubicin T cells, percent viability   [%]     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 35 m 10wks N=4 2015
    Wiltshire4 52433 immune cell quantification doxorubicin monocytes, percent viability   [%]     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 35 m 10wks N=4 2015
    All boxes